TREATMENT WITH RESMETIROM IN PHASE 3 MAESTRO-NAFLD-1 NASH STUDY OPEN LABEL ARM: EFFECTS ON BIOMARKERS AND IMAGING
Publication
, Conference
Harrison, SA; Alkhouri, N; Taub, RA; Neff, G; Baum, SJ; Bashir, M
Published in: HEPATOLOGY
2020
Duke Scholars
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
2020
Volume
72
Start / End Page
1040 / 1041
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Harrison, S. A., Alkhouri, N., Taub, R. A., Neff, G., Baum, S. J., & Bashir, M. (2020). TREATMENT WITH RESMETIROM IN PHASE 3 MAESTRO-NAFLD-1 NASH STUDY OPEN LABEL ARM: EFFECTS ON BIOMARKERS AND IMAGING. In HEPATOLOGY (Vol. 72, pp. 1040–1041).
Harrison, Stephen A., Naim Alkhouri, Rebecca A. Taub, Guy Neff, Seth J. Baum, and Mustafa Bashir. “TREATMENT WITH RESMETIROM IN PHASE 3 MAESTRO-NAFLD-1 NASH STUDY OPEN LABEL ARM: EFFECTS ON BIOMARKERS AND IMAGING.” In HEPATOLOGY, 72:1040–41, 2020.
Harrison SA, Alkhouri N, Taub RA, Neff G, Baum SJ, Bashir M. TREATMENT WITH RESMETIROM IN PHASE 3 MAESTRO-NAFLD-1 NASH STUDY OPEN LABEL ARM: EFFECTS ON BIOMARKERS AND IMAGING. In: HEPATOLOGY. 2020. p. 1040–1.
Harrison, Stephen A., et al. “TREATMENT WITH RESMETIROM IN PHASE 3 MAESTRO-NAFLD-1 NASH STUDY OPEN LABEL ARM: EFFECTS ON BIOMARKERS AND IMAGING.” HEPATOLOGY, vol. 72, 2020, pp. 1040–41.
Harrison SA, Alkhouri N, Taub RA, Neff G, Baum SJ, Bashir M. TREATMENT WITH RESMETIROM IN PHASE 3 MAESTRO-NAFLD-1 NASH STUDY OPEN LABEL ARM: EFFECTS ON BIOMARKERS AND IMAGING. HEPATOLOGY. 2020. p. 1040–1041.
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
2020
Volume
72
Start / End Page
1040 / 1041
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics